Publications by authors named "Raymond Rynberg"

Claim this Profile
H
Heteroarylureas with fused bicyclic diamine cores as inhibitors of fatty acid amide hydrolase.
John M Keith, William Jones, Joan M Pierce, Mark Seierstad, James A Palmer, Raymond Rynberg

Bioorg Med Chem Lett· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors.
John M Keith, Mark S Tichenor, Richard L Apodaca, Wei Xiao, William M Jones, Raymond Rynberg

Bioorg Med Chem Lett· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279.
John M Keith, William M Jones, Mark Tichenor, Jing Liu, Mark Seierstad, Raymond Rynberg

ACS Med Chem Lett· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase.
John M Keith, William M Jones, Joan M Pierce, Mark Seierstad, James A Palmer, Raymond Rynberg

Bioorg Med Chem Lett· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrazole-based arylalkyne cathepsin S inhibitors. Part III: modification of P4 region.
John J M Wiener, Alvah Tyson Wickboldt, Steven Nguyen, Siquan Sun, Raymond Rynberg

Bioorg Med Chem Lett· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate.
John M Keith, Rich Apodaca, Mark Tichenor, Wei Xiao, William Jones, Raymond Rynberg

ACS Med Chem Lett· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,2-diamino-ethane-substituted-6,7,8,9-tetrahydro-5H-pyrimido[4,5-d]azepines as TRPV1 antagonists with improved properties.
Alec D Lebsack, Jason C Rech, Bryan J Branstetter, Natalie A Hawryluk, Jeffrey E Merit, Raymond Rynberg

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: identification of candidates for clinical development.
Michael A Letavic, Leah Aluisio, John R Atack, Pascal Bonaventure, Nicholas I Carruthers, Raymond Rynberg

Bioorg Med Chem Lett· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical synthesis of a Cathepsin S inhibitor: route identification, purification strategies, and serendipitous discovery of a crystalline salt form.
Xiaohu Deng, Jimmy T Liang, Matthew Peterson, Raymond Rynberg, Eugene Cheung

J Org Chem· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and synthesis of 2,7-diamino-thiazolo[5,4-d]pyrimidine derivatives as TRPV1 antagonists.
Alec D Lebsack, Bryan J Branstetter, Michael D Hack, Wei Xiao, Matthew L Peterson, Raymond Rynberg

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Aryl benzimidazoles featuring alkyl-linked pendant alcohols and amines as inhibitors of checkpoint kinase Chk2.
Danielle K Neff, Alice Lee-Dutra, Jonathan M Blevitt, Frank U Axe, Michael D Hack, Raymond Rynberg

Bioorg Med Chem Lett· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis